Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals and improved drug safety ...
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced an enhanced risk monitoring and pharmacovigilance solution with Embase, its ...
LONDON, June 25, 2025 /PRNewswire/ -- Elsevier introduces Embase AI, a GenAI-powered version of Embase, the leading biomedical literature database. Embase AI transforms literature searches and other ...
DistillerSR's literature review platform to provide turn-key integrated access to Embase' API, greatly enhancing and simplifying the review process By enabling users to search, import, and enrich ...
Systematic reviews remain a cornerstone of evidence‐based research, providing comprehensive syntheses of primary study findings to support clinical and policy decision-making. Central to the integrity ...
London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, ...
With Embase and PharmaPendium, researchers can monitor pre-clinical, clinical and post-market information from a single search - improving pharmacovigilance and risk monitoring Elsevier, a ...
Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals and improved drug safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results